| 发明名称 |
Fused heteroaryl derivatives |
| 摘要 |
The present invention provides a pharmaceutical composition which is useful as a phosphatidylinositol 3 kinase (PI3K) inhibitor and an antitumor agent, and it provides a novel bicyclic or tricyclic fused heteroaryl derivative or a salt thereof which possesses an excellent PI3K inhibiting activity and cancer cell growth inhibiting activity. |
| 申请公布号 |
US8067586(B2) |
申请公布日期 |
2011.11.29 |
| 申请号 |
US20100688272 |
申请日期 |
2010.01.15 |
| 申请人 |
HAYAKAWA MASAHIKO;KAIZAWA HIROYUKI;MORITOMO HIROYUKI;KAWAGUCHI KEN-ICHI;KOIZUMI TOMONOBU;YAMANO MAYUMI;MATSUDA KOYO;OKADA MINORU;OHTA MITSUAKI;ASTELLAS PHARMA INC.;LUDWIG INSTITUTE FOR CANCER RESEARCH;IMPERIAL CANCER RESEARCH TECHNOLOGY LTD. |
发明人 |
HAYAKAWA MASAHIKO;KAIZAWA HIROYUKI;MORITOMO HIROYUKI;KAWAGUCHI KEN-ICHI;KOIZUMI TOMONOBU;YAMANO MAYUMI;MATSUDA KOYO;OKADA MINORU;OHTA MITSUAKI |
| 分类号 |
C07D413/00;A61K31/00;A61K31/517;A61K31/519;A61K31/5377;C07D471/04;C07D471/14;C07D491/04;C07D491/14;C07D495/04;C07D495/14 |
主分类号 |
C07D413/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
